Signal: Eli Lilly’s $176.5m Teva patent infringement loss overturned in US
A District Judge overturned last year's jury verdict, declaring the application of Teva's patents overly broad.
Filings
Signal: Illumina leads $15m investment in Broken String Biosciences
Signal: Novo Nordisk market cap higher than Danish GDP due to obesity drugs
Signal: Abortion pill restriction may drive more patients to off-label drug
Filings signal: Despite Covid losses, pharma earnings are promising
Filings signal: Despite losses, medtech companies feel hopeful
Sentiment in the medical industry increased in Q2 2023
How did the medical industry treat robotics in Q2 2023 filings?
